Nurix Therapeutics, Inc. SEC filings NRIX
Nurix Therapeutics, Inc. has 561 filings in SEC EDGAR's recent list, going back to May 15, 2012. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Nov 30, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 13, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on November 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Oct 13, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 13, 2026 | Oct 12, 2026 |
| 10-Q | Quarterly report | Jul 9, 2026 | May 31, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 9, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 8, 2026 | Jun 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | Apr 8, 2026 | Feb 28, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 8, 2026 | Apr 8, 2026 |
| ARS | Annual report to shareholders | Mar 27, 2026 | Nov 30, 2025 |
| DEFA14A | Additional proxy material | Mar 27, 2026 | — |
| DEF 14A | Proxy statement | Mar 27, 2026 | May 15, 2026 |
| 8-K |
Current report
Other events
|
Mar 6, 2026 | Mar 6, 2026 |
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| S-8 | Employee stock plan registration | Jan 28, 2026 | — |
| 10-K | Annual report | Jan 28, 2026 | Nov 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 9, 2025 | Dec 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 10, 2025 | Nov 6, 2025 |
| 424B5 | Prospectus supplement | Oct 22, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 22, 2025 | Oct 22, 2025 |
| FWP | Free writing prospectus | Oct 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 22, 2025 | Oct 22, 2025 |
| 10-Q | Quarterly report | Oct 9, 2025 | Aug 31, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 9, 2025 | Oct 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 22, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Jul 9, 2025 | May 31, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 12, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 19, 2025 |
| 10-Q | Quarterly report | Apr 8, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 8, 2025 | Apr 8, 2025 |
| DEFA14A | Additional proxy material | Mar 28, 2025 | — |
| ARS | Annual report to shareholders | Mar 28, 2025 | Nov 30, 2024 |
| DEF 14A | Proxy statement | Mar 28, 2025 | May 19, 2025 |
| UPLOAD | Letter from the SEC | Mar 19, 2025 | — |
| CORRESP | Letter to the SEC | Mar 13, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 13, 2025 | Mar 11, 2025 |
| UPLOAD | Letter from the SEC | Feb 28, 2025 | — |
| S-8 | Employee stock plan registration | Jan 28, 2025 | — |
| 10-K | Annual report | Jan 28, 2025 | Nov 30, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 9, 2024 |
| 424B5 | Prospectus supplement | Oct 31, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 31, 2024 | Oct 31, 2024 |
| S-8 | Employee stock plan registration | Oct 31, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2024 | Oct 15, 2024 |
| 10-Q | Quarterly report | Oct 11, 2024 | Aug 31, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 11, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2024 | Sep 5, 2024 |
| 424B5 | Prospectus supplement | Jul 11, 2024 | — |
| 10-Q | Quarterly report | Jul 11, 2024 | May 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 11, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2024 | Jun 16, 2024 |
| S-3ASR | Automatic shelf registration | Jun 11, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2024 | May 20, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 12, 2024 | Apr 11, 2024 |
| 424B5 | Prospectus supplement | Apr 12, 2024 | — |
| 424B5 | Prospectus supplement | Apr 11, 2024 | — |
| 10-Q | Quarterly report | Apr 10, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Apr 9, 2024 | Apr 9, 2024 |
| ARS | Annual report to shareholders | Mar 27, 2024 | Nov 30, 2023 |
| DEFA14A | Additional proxy material | Mar 27, 2024 | — |
| DEF 14A | Proxy statement | Mar 27, 2024 | May 20, 2024 |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 11, 2024 |
| S-8 | Employee stock plan registration | Feb 15, 2024 | — |
| 10-K | Annual report | Feb 15, 2024 | Nov 30, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Other events
|
Nov 1, 2023 | Nov 1, 2023 |
| 10-Q | Quarterly report | Oct 12, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 7, 2023 | Sep 6, 2023 |
| 10-Q | Quarterly report | Jul 13, 2023 | May 31, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 13, 2023 | Jul 13, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 4, 2023 | May 4, 2023 |
| 10-Q | Quarterly report | Apr 13, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 13, 2023 | Apr 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2023 | Apr 5, 2023 |
| EFFECT | Filing | Apr 6, 2023 | — |
| ARS | Annual report to shareholders | Mar 24, 2023 | Nov 30, 2022 |
| DEFA14A | Additional proxy material | Mar 24, 2023 | — |
| DEF 14A | Proxy statement | Mar 24, 2023 | May 4, 2023 |
| 8-K |
Current report
Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| S-8 | Employee stock plan registration | Feb 9, 2023 | — |
| POS AM | Filing | Feb 9, 2023 | — |
| 10-K | Annual report | Feb 9, 2023 | Nov 30, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2023 | Feb 9, 2023 |
| POSASR | Filing | Feb 9, 2023 | — |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 16, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Other events
|
Dec 13, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Other events
|
Oct 26, 2022 | Oct 26, 2022 |
| 10-Q | Quarterly report | Oct 6, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 6, 2022 | Oct 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 14, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 8, 2022 | Jul 7, 2022 |
| 424B5 | Prospectus supplement | Jul 8, 2022 | — |
| 424B5 | Prospectus supplement | Jul 8, 2022 | — |
| 10-Q | Quarterly report | Jul 7, 2022 | May 31, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 7, 2022 | Jul 7, 2022 |
| 8-K |
Current report
Other events
|
May 26, 2022 | May 26, 2022 |
| 8-K |
Current report
Officer or director change
|
May 16, 2022 | May 15, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 6, 2022 | May 5, 2022 |
| 10-Q | Quarterly report | Apr 8, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 7, 2022 | Apr 7, 2022 |
| DEFA14A | Additional proxy material | Mar 25, 2022 | — |
| DEF 14A | Proxy statement | Mar 25, 2022 | May 5, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Material agreement
|
Mar 2, 2022 | Mar 1, 2022 |
| S-8 | Employee stock plan registration | Jan 28, 2022 | — |
| 10-K | Annual report | Jan 28, 2022 | Nov 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 27, 2022 | Jan 27, 2022 |
| 8-K |
Current report
Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Other events
|
Oct 27, 2021 | Oct 27, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 14, 2021 | Oct 14, 2021 |
| 10-Q | Quarterly report | Oct 14, 2021 | Aug 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2021 | Sep 25, 2021 |
| S-3ASR | Automatic shelf registration | Aug 4, 2021 | — |
| 10-Q | Quarterly report | Jul 13, 2021 | May 31, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 13, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 9, 2021 | Jul 8, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2021 | Jun 14, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 1, 2021 | May 28, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 10, 2021 | May 6, 2021 |
| 10-Q | Quarterly report | Apr 13, 2021 | Feb 28, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 13, 2021 | Apr 13, 2021 |
| DEFA14A | Additional proxy material | Mar 25, 2021 | — |
| DEF 14A | Proxy statement | Mar 25, 2021 | May 6, 2021 |
| 424B4 | Prospectus | Mar 5, 2021 | — |
| POS EX | Filing | Mar 5, 2021 | — |
| EFFECT | Filing | Mar 4, 2021 | — |
| CORRESP | Letter to the SEC | Mar 2, 2021 | — |
| CORRESP | Letter to the SEC | Mar 2, 2021 | — |
| S-1 | Registration statement | Mar 2, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2021 | — |
| DRS | Filing | Feb 22, 2021 | — |
| S-8 | Employee stock plan registration | Feb 16, 2021 | — |
| 10-K | Annual report | Feb 16, 2021 | Nov 30, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 16, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2020 | Dec 7, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 26, 2020 | Oct 23, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 14, 2020 | Oct 14, 2020 |
| 10-Q | Quarterly report | Oct 14, 2020 | Aug 31, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2020 | Oct 14, 2020 |
| 424B4 | Prospectus | Jul 24, 2020 | — |
| S-8 | Employee stock plan registration | Jul 24, 2020 | — |
| EFFECT | Filing | Jul 23, 2020 | — |
| CERT | Filing | Jul 23, 2020 | — |
| S-1/A | Amended registration statement | Jul 23, 2020 | — |
| CORRESP | Letter to the SEC | Jul 21, 2020 | — |
| CORRESP | Letter to the SEC | Jul 21, 2020 | — |
| 8-A12B | Filing | Jul 20, 2020 | — |
| S-1/A | Amended registration statement | Jul 20, 2020 | — |
| CORRESP | Letter to the SEC | Jul 10, 2020 | — |
| S-1 | Registration statement | Jul 2, 2020 | — |
| DRSLTR | Filing | Jun 10, 2020 | — |
| DRS/A | Filing | Jun 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2020 | — |
| DRS | Filing | May 5, 2020 | — |
| D | Filing | Mar 26, 2020 | — |
| D | Filing | Sep 18, 2015 | — |
| D | Filing | Jan 2, 2014 | — |
| D/A | Filing | Mar 28, 2013 | — |
| D | Filing | May 16, 2012 | — |
| D | Filing | May 15, 2012 | — |
Showing 174 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NRIX (Nasdaq)
- Fiscal year ends
- November 30
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1549595
- Former names
- Nurix, Inc. (until Sep 18, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.